
    
      A Prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and
      effectiveness of transcatheter tricuspid valve repair with the Edwards PASCAL Transcatheter
      Valve Repair System and optimal medical therapy (OMT) compared to OMT alone in patients with
      tricuspid regurgitation. Patients will be seen for follow-up visits at discharge, 30 days, 3
      months, 6 months, and annually through 5 years.
    
  